Octagon Capital Advisors’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	43
2023 Q3	–	Sell	-495,000	Closed	-$7.6M	–	42
2023 Q2	$7.6M	Hold	495,000	–	–	1.06%	20
2023 Q1	$11.1M	Buy	+495,000	New	+$11.1M	1.6%	14